Literature DB >> 9201236

Chronic cold agglutinin disease of the "idiopathic" type is a premalignant or low-grade malignant lymphoproliferative disease.

S Berentsen1, K Bø, F V Shammas, A O Myking, E Ulvestad.   

Abstract

We investigated the clinical, pathological, and immunological features of "idiopathic" cold agglutinin disease (CAD) in a population-based study. Fourteen patients were studied, giving a prevalence of about 14 per million with a mean age of 75 years. Haemolysis was present in all cases, but only eight patients had clinical symptoms of peripheral haemagglutination. Serum electrophoresis, immunofixation, morphological bone marrow evaluation, and flow cytometric immunophenotyping were used to detect any monoclonal lymphoproliferative disorder. Flow cytometry seemed to be a sensitive way to demonstrate a clonal B-cell proliferation. Some evidence of clonality was found in 13 patients, and a clonal lymphoproliferative disease was documented by flow cytometry or biopsy in 10 out of 11 patients. We conclude that CAD is a symptom-producing monoclonal lymphoproliferative disorder in nearly all patients.

Entities:  

Mesh:

Year:  1997        PMID: 9201236     DOI: 10.1111/j.1699-0463.1997.tb00581.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  7 in total

1.  Cold antibody autoimmune hemolytic anemia and lymphoproliferative disorders: a retrospective study of 20 patients including clinical, hematological, and molecular findings.

Authors:  Cathrin Arthold; Cathrin Skrabs; Gerlinde Mitterbauer-Hohendanner; Renate Thalhammer; Ingrid Simonitsch-Klupp; Simon Panzer; Peter Valent; Klaus Lechner; Ulrich Jäger; Christian Sillaber
Journal:  Wien Klin Wochenschr       Date:  2014-05-20       Impact factor: 1.704

2.  Cold agglutinin disease burden: a longitudinal analysis of anemia, medications, transfusions, and health care utilization.

Authors:  Megan Mullins; Xiaohui Jiang; Lauren C Bylsma; Jon P Fryzek; Heidi Reichert; Evan C Chen; Shivaani Kummar; Adam Rosenthal
Journal:  Blood Adv       Date:  2017-05-19

3.  Occurrence of lymphoplasmacytic lymphoma 6 years after amelioration of primary cold agglutinin disease by rituximab therapy.

Authors:  Hiroaki Tanaka; Shinichiro Hashimoto; Yasumasa Sugita; Shio Sakai; Yusuke Takeda; Daijiro Abe; Toshiyuki Takagi; Chiaki Nakaseko
Journal:  Int J Hematol       Date:  2012-08-11       Impact factor: 2.490

Review 4.  The Clinical Pictures of Autoimmune Hemolytic Anemia.

Authors:  Charles H Packman
Journal:  Transfus Med Hemother       Date:  2015-09-11       Impact factor: 3.747

Review 5.  New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.

Authors:  Sigbjørn Berentsen
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

6.  Cryoglobulinemic vasculitis with interruption of ibrutinib therapy for chronic lymphocytic leukemia (CLL).

Authors:  Nicholas Wright; Ensi Voshtina; Gemlyn George; Arun Singavi; Joshua Field
Journal:  Int J Hematol       Date:  2019-09-07       Impact factor: 2.319

Review 7.  Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.

Authors:  Sigbjørn Berentsen; Klaus Beiske; Geir E Tjønnfjord
Journal:  Hematology       Date:  2007-10       Impact factor: 2.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.